CarsSmart
Roswell Park launches a CAR T trial for ovarian cancer
An exclusive U.S. study will test an “armored” cell therapy designed to boost activity against ovarian cancer.
2 October 2026 1 min read 1 views
Roswell Park Comprehensive Cancer Center has launched a new clinical study with Generate Biomedicines to test an “armored” CAR T therapy against ovarian cancer. The goal is to see whether engineered cells can better survive the tumor’s hostile environment and attack it more effectively.
For Italian readers, this is an important step in cancer research: CAR T treatments have already changed care for some blood cancers, but solid tumors remain a major challenge. This trial aims to tackle that gap.
Follow MOTORINEWS24 on Google · Add us to your preferred sources: our news will show at the top of Google results.
Add to preferred sources
Also read on Readoo- Due vallate e 200 km attorno al Passo Stalle
- Bilancio 2026, testo bollinato: 157 articoli con nuove misure
- La QJ Motor Rino 900 debutta con 119 CV
- Moto Morini, Bezzi disegna la 7½ Sport col V2